REFERENCES
- Franz H. Mistletoe lectins and their A and B chains. Oncology 1986; 43(Suppl 1)23–34
- Dietrich J B, Ribereau-Gayon G, Jung M L, Franz H, Beck J P, Anton R. Identity of the N-terminal sequences of the three A chains of mistletoe (Viscum album L.) lectins: homology with ricin-like plant toxins and single-chain ribosome-inhibiting proteins. Anticancer Drugs 1992; 3(5)507–11
- Bussing A, Suzart K, Bergmann J, Pfuller U, Schietzel M, Schweizer K. Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins. Cancer Lett 1996; 99(1)59–72
- Lee H S, Kim Y S, Kim S B, Choi B E, Woo B H, Lee K C. Isolation and characterization of biologically active lectin from Korean mistletoe, Viscum album var. Coloratum. Cell Mol Life Sci 1999; 55(4)679–82
- Park R K, Kim M S, So H S, Jung B H, Moon S R, Chung S Y, Ko C B, Chung H T. Activation of c-Jun N-Terminal Kinasel (JNK1) in Mistletoe lectin-II-Induced Apoptosis of Human Myeloleukemic U937 Cells. Biochem Pharmacol, (In press), 2000
- Searle J, Kerr J F, Bishop C J. Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance. Pathol Annu 1982; 17(Pt 2)229–59
- Cohen J J. Apoptosis. Immunol Today 1993; 14(3)126–30
- Sen G C, Lengyel P. The interferon system. A bird's eye view of its biochemistry. J Biol Chem 1992; 267(8)5017–20
- Kikuchi H, Iizuka R, Sugiyama S, Gon G, Mori H, Arai M, Mizumoto K, Imajoh-Ohmi S. Monocytic differentiation modulates apoptotic response to cytotoxic anti-Fas antibody and tumor necrosis factor alpha in human monoblast U937 cells. J Leukoc Biol 1996; 60(6)778–83
- Friesen C, Herr I, Krammer P H, Debatin K M. Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat Med 1996; 2(5)574–7
- Muzio M, Chinnaiyan A M, Kischkel F C, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz J D, Zhang M, Gentz R, Mann M, Krammer P H, Peter M E, Dixit V M. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death—inducing signaling complex. Cell 1996; 85(6)817–27
- Kaufmann S H, Desnoyers S, Ottaviano Y, Davidson N E, Poirier G G. Specific proteolytic cleavage of poly (ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 1993; 53(17)3976–85
- Nicholson D W, Ali A, Thornberry N A, Vaillancourt J P, Ding C K, Gallant M, Gareau Y, Griffin P R, Labelle M, Lazebnik Y A, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis [see comments]. Nature 1995; 376(6535)37–43
- Bump N J, Hackett M, Hugunin M, Seshagiri S, Brady K, Chen P, Ferenz C, Franklin S, Ghayur T, Li P, et al. Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science 1995; 269(5232)1885–8
- Micheau O, Solary E, Hammann A, Dimanche-Boitrel M T. Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs. J Biol Chem 1999; 274(12)7987–92
- Taniguchi T. IRF-1 and IRF-2 as regulators of the interferon system and cell growth. Indian J Biochem Biophys 1995; 32(5)235–9
- Tamura T, Ishihara M, Lamphier M S, Tanaka N, Oishi I, Aizawa S, Matsuyama T, Mak T W, Taki S, Taniguchi T. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature 1995; 376(6541)596–9
- Kanzaki M, Morris P L. Identification and regulation of testicular interferon-gamma (IFNgamma) receptor subunits: IFNgamma enhances interferon regulatory factor-1 and interleukin-1beta converting enzyme expression. Endocrinology 1998; 139(5)2636–44